Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,545
datasets available to search
ShareScore release 0.9.0
Dataset results
1,545 results for “type 2 diabetes mellitus”
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
ClinicalTrials.gov study NCT02545842. IPD Sharing: YES. Countries: 1. Publications: 4.
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01106651. IPD Sharing: Not stated. Countries: 17. Publications: 8.
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02111096. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT03555994. IPD Sharing: YES. Countries: 3. Publications: 1.
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02229227. IPD Sharing: YES. Countries: 14. Publications: 1.
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03736785. IPD Sharing: YES. Countries: 3. Publications: 1.
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01144338. IPD Sharing: Not stated. Countries: 35. Publications: 18.
Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01650259. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01652729. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
ClinicalTrials.gov study NCT01649297. IPD Sharing: Not stated. Countries: 18. Publications: 1.
A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03018938. IPD Sharing: YES. Countries: 1. Publications: 1.
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00765817. IPD Sharing: Not stated. Countries: 6. Publications: 5.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01316341. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
ClinicalTrials.gov study NCT01042977. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of LX4211 in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00962065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01947855. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
ClinicalTrials.gov study NCT03936660. IPD Sharing: NO. Countries: 1. Publications: 8.
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01294423. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01364428. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
ClinicalTrials.gov study NCT00663260. IPD Sharing: Not stated. Countries: 13. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.